Balchem Corporation Reports First Quarter Sales of $174.4 Million, GAAP EPS of $0.61 and Adjusted EPS of $0.81
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Balchem Corp. (BCPC) Tops Q1 EPS by 21c, Revenues Beat
May 1, 2020 7:09 AM EDTBalchem Corp. (NASDAQ: BCPC) reported Q1 EPS of $0.81, $0.21 better than the analyst estimate of $0.60. Revenue for the quarter came in at $174.4 million versus the consensus estimate of $169.87 million.
First Quarter 2020 Financial Highlights:
Net sales of $174.4 million, an increase of $17.4 million, or 11.1%, compared to the prior year quarter.Year over year sales growth in Human Nutrition and Heath, Animal Nutrition and Health, and Specialty Products.First quarter GAAP net earnings were $19.8 million, an increase of $1.0 million, or 5.2% from the prior year. These net earnings resulted in GAAP earnings per... More